Norway's OTC Market In 2018: Sales Remain Stable As GSK Consolidates Its Leading Position
Sales of non-prescription medicines in Norway edged up by less than 1% in 2018, as GSK remained the leading player on the market and its Otrivin respiratory line maintained its position as the country's best-selling OTC brand.
